Cat No.C-073
OrganismHuman
TissueGallbladder
DiseaseCancer
Growth PropertiesEmbedded 3D Culture
Biosafety Level1
Growth conditions37℃, 95% Air, 5% CO2
Size/Quantity1
Product formatFrozen
Shipping InfoDry Ice
Storage conditionsLiquid Nitrogen

View Product Image

Description

Human Gallbladder Cancer Organoids are advanced 3D in vitro tumor models derived from patient gallbladder cancer tissues. They preserve key pathological features, including tumor heterogeneity, genetic mutations, and drug response profiles. Suitable for cancer biology research, biomarker discovery, and precision drug screening, these organoids provide a reliable platform for studying gallbladder cancer progression and evaluating therapeutic strategies.

Specifications & Applications

Growth Properties

Embedded 3D Culture

Quality Control

All test negative for mycoplasma, bacteria, yeast, and fungi.

Application

For research use only. Tissue-derived organoids are widely used in drug screening, disease modeling, mechanism research, personalized medicine, and regenerative medicine. By simulating authentic disease states, these organoids provide an ideal platform to assess patient responses to new drugs and assist in the design of personalized treatment plans. Additionally, they drive the development of new therapeutic approaches, particularly in cancer research and organ regeneration, offering precise experimental tools that greatly enhance the advancement of precision medicine.

Tags

Inquiring Human Gallbladder Cancer Organoid

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.

Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.

Let's build the future of translational research together.

Let's Talk Now

Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.

Let's build the future of translational research together.

Let's Talk Now